Skip to main content

Table 1 OPTIMISE Study: Targets set for benchmarking

From: Study rationale and design of OPTIMISE, a randomised controlled trial on the effect of benchmarking on quality of care in type 2 diabetes mellitus

 

SBP

(mmHg)

LDL-cholesterol

(mg/dL)

HbA1c

(%)

All countries

< 130*

< 100†

< 7.0

Belgium

 

< 80†

 
  1. *Patients with proteinuria < 125 mmHg
  2. †Patients with existing coronary heart disease < 70 mg/dL
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840